| TOTAL | $7.31M |
| VENTURE FUNDING TOTAL | $7.31M |
| Venture Round, 4/11 IBB Beteiligungsgesellschaft mbH KfW Mittelstandsbank | €5M |
OctreoPharm Sciences GmbH is a Berlin, Germany-based a biopharmaceutical company that focuses on the development of new radio pharmaceuticals for neuroendocrine tumours.